Which phase involves post-approval studies and ongoing safety assessment?

Which phase involves post-approval studies and ongoing safety assessment?

• A. Pre-clinical
• B. Clinical trials
• C. Post-marketing research
• D. Regulatory submission

Answer: (C)

Post-approval studies and ongoing safety assessment happen after a medicine is approved to monitor how it performs in the real world over longer periods and in larger, more diverse patient groups. This phase, often called post-marketing surveillance or Phase IV, focuses on long-term safety, rare adverse events, and the effectiveness of risk management plans. It fills the gap after pre-clinical and clinical trials by continuing to collect data once the product is in widespread use and subjected to real-world conditions. That’s why this option best describes the phase in which post-approval studies and ongoing safety assessment occur. Pre-clinical and clinical trials occur before approval, and regulatory submission is the process of compiling and presenting data to obtain approval, not the ongoing safety monitoring after approval.

Post-approval studies and ongoing safety assessment happen after a medicine is approved to monitor how it performs in the real world over longer periods and in larger, more diverse patient groups. This phase, often called post-marketing surveillance or Phase IV, focuses on long-term safety, rare adverse events, and the effectiveness of risk management plans. It fills the gap after pre-clinical and clinical trials by continuing to collect data once the product is in widespread use and subjected to real-world conditions. That’s why this option best describes the phase in which post-approval studies and ongoing safety assessment occur. Pre-clinical and clinical trials occur before approval, and regulatory submission is the process of compiling and presenting data to obtain approval, not the ongoing safety monitoring after approval.